|
EXOC8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.216800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.186900E-04 |
| Normal-vs-Stage2 |
2.935300E-03 |
| Normal-vs-Stage3 |
9.120100E-02 |
| Normal-vs-Stage4 |
1.084070E-02 |
| Stage1-vs-Stage2 |
8.249600E-01 |
| Stage1-vs-Stage3 |
1.380610E-01 |
| Stage1-vs-Stage4 |
8.483600E-01 |
| Stage2-vs-Stage3 |
3.550200E-01 |
| Stage2-vs-Stage4 |
7.326200E-01 |
| Stage3-vs-Stage4 |
3.374000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.72079999999953E-05 |
| Normal-vs-AfricanAmerican |
2.035600E-03 |
| Normal-vs-Asian |
1.268060E-02 |
| Caucasian-vs-AfricanAmerican |
5.944800E-01 |
| Caucasian-vs-Asian |
6.214600E-01 |
| AfricanAmerican-vs-Asian |
5.716600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32880000003333E-06 |
| Normal-vs-Female |
5.705800E-02 |
| Male-vs-Female |
8.241100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.540100E-02 |
| Normal-vs-Extreme_Weight |
3.7580999978637E-08 |
| Normal-vs-Obese |
3.899600E-03 |
| Normal-vs-Extreme_Obese |
1.597870E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.734000E-02 |
| Normal_Weight-vs-Obese |
9.581200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.725000E-01 |
| Extreme_Weight-vs-Obese |
1.130180E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.294600E-01 |
| Obese-vs-Extreme_Obese |
7.058800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.620100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.301270E-03 |
| Normal-vs-Age(61-80Yrs) |
1.59483999999654E-05 |
| Normal-vs-Age(81-100Yrs) |
2.234900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.416800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.778360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.212400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.140100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.482400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.281000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.70829999987821E-07 |
| Normal-VS-Type2 PRCC |
1.788160E-02 |
| Normal-VS-KIRP CIMP |
1.063170E-01 |
| Normal-VS-Unclassified PRCC |
2.024200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.090100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.138200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.198400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.866800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.718400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.648200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.41019999969572E-07 |
| Normal-vs-N1 |
4.820000E-01 |
| Normal-vs-N2 |
1.439800E-02 |
| N0-vs-N1 |
9.220800E-03 |
| N0-vs-N2 |
6.892600E-01 |
| N1-vs-N2 |
1.606160E-01 |
|
|
